MESSEMER DEBORAH M. 4
4 · Allogene Therapeutics, Inc. · Filed Jun 12, 2025
Insider Transaction Report
Form 4
MESSEMER DEBORAH M.
Director
Transactions
- Sale
Common Stock
2025-06-10$1.42/sh−36,885$52,377→ 107,431 total
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 8/30/2024.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $1.38 to $1.445, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.